BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10604950)

  • 1. Coupling of human delta-opioid receptor to retinal rod transducin in Chinese hamster ovary cells.
    Varga EV; Stropova D; Kim T; Wang M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 2000 Jan; 292(1):209-14. PubMed ID: 10604950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of alpha-transducin in Chinese hamster ovary cells stably transfected with the human delta-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation.
    Rubenzik M; Varga E; Stropova D; Roeske WR; Yamamura HI
    Mol Pharmacol; 2001 Nov; 60(5):1076-82. PubMed ID: 11641436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
    Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of [35S]guanosine-5'-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay.
    DeLapp NW; McKinzie JH; Sawyer BD; Vandergriff A; Falcone J; McClure D; Felder CC
    J Pharmacol Exp Ther; 1999 May; 289(2):946-55. PubMed ID: 10215674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type-specific differences in the coupling of recombinant mGlu1alpha receptors to endogenous G protein sub-populations.
    Selkirk JV; Price GW; Nahorski SR; Challiss RA
    Neuropharmacology; 2001 Apr; 40(5):645-56. PubMed ID: 11311892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
    Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
    Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association.
    Kong H; Raynor K; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):380-4. PubMed ID: 8102784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of inverse agonism at the delta opioid receptor after expression in Rat 1 fibroblasts.
    Mullaney I; Carr IC; Milligan G
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):227-34. PubMed ID: 8670111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptor.
    Quock RM; Hosohata Y; Knapp RJ; Burkey TH; Hosohata K; Zhang X; Rice KC; Nagase H; Hruby VJ; Porreca F; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1997 May; 326(1):101-4. PubMed ID: 9178661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity.
    Zádor F; Kocsis D; Borsodi A; Benyhe S
    Neurochem Int; 2014 Feb; 67():14-22. PubMed ID: 24508403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-specific down-regulation of the human delta-opioid receptor.
    Okura T; Varga EV; Hosohata Y; Navratilova E; Cowell SM; Rice K; Nagase H; Hruby VJ; Roeske WR; Yamamura HI
    Eur J Pharmacol; 2003 Jan; 459(1):9-16. PubMed ID: 12505529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of human delta opioid receptor desensitization using the operational model of drug action.
    Navratilova E; Waite S; Stropova D; Eaton MC; Alves ID; Hruby VJ; Roeske WR; Yamamura HI; Varga EV
    Mol Pharmacol; 2007 May; 71(5):1416-26. PubMed ID: 17322005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of a Leu-Gly-Asn repeat-enriched protein (LGN), a putative binding partner of transducin, in ROD photoreceptors.
    Nair KS; Mendez A; Blumer JB; Rosenzweig DH; Slepak VZ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):383-9. PubMed ID: 15623799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K; Varga EV; Alfaro-Lopez J; Tang X; Vanderah TW; Porreca F; Hruby VJ; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 2003 Feb; 304(2):683-8. PubMed ID: 12538822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide and related compounds at the cloned human delta-opioid receptor.
    Xu H; Lu YF; Thomas JB; Carroll FI; Rice KC; Rothman RB
    Synapse; 2001 Jun; 40(4):269-74. PubMed ID: 11309842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-, antagonist-, and inverse agonist-regulated trafficking of the delta-opioid receptor correlates with, but does not require, G protein activation.
    Zaki PA; Keith DE; Thomas JB; Carroll FI; Evans CJ
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1015-20. PubMed ID: 11504798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG; Traynor JR
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
    Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F
    J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.